Table 5.
Subjects | Location | Acupoint | Intervention | Time of intervention | Signal pathway | Main results | Author, reference |
---|---|---|---|---|---|---|---|
Male, SD rat, scopolamine injection | brain | GV20 | MA | pretreatment for 5 min, QD for 14 days | enhance cholinergic system-CREB-BDNF pathway | elevation of choline acetyltransferase, choline transporter 1, vesicular acetylcholine transporter, BDNF, CREB proteins neuroprotection |
Lee B, et al. 2014[135] |
| |||||||
APP/PS1 mice | brain | GV20 | EA, 1/20 Hz | 30min, QD for 4 weeks | modulation of BDNF-TrkB pathway | elevation of BDNF/proBDNF ratio, p-TrkB depression of β-amyloid (1-42), p75 anti-apoptosis |
Lin R, et al. 2016[136] |
| |||||||
Male, SAMP10 | hippocampus | CV17, CV12, CV6, ST36, SP10 | MA | QD | regulation of aging gene | elevation of p53, Mad related protein 2, Nucleoside diphosphate kinase B, AT motif-binding factor, Hsp84, Hsp86 depression of p38 MAPK, retinoblastoma-associated protein 1 anti-oxidation |
Ding X, et al. 2006[18] |
| |||||||
SD rat, Aβ1-40 injection | hippocampus, frontal cortex | GV20, KI3, ST36 | EA, 1mA, 2Hz | 15min, QD for 12 days | inactivation of p38 MAPK pathway | depression of p-p38 MAPK protein, IL-1beta mRNA decrease neuroinflammation |
Fang JQ, et al. 2013[137] |
| |||||||
Male, SD rat, Aβ1-40 injection | hippocampus CA1 | GV20, BL23 | EA, 2mA, 2-4V, 2Hz | 20min, QD, 6 days/ wk for 4 weeks | activation of PPAR-γ pathway | elevation of PPAR-γ depression of p-p38MAPK, Aβ, p-Tau Ser404 protein decrease neuroinflammation |
Zhang M, et al. 2017[138] |
| |||||||
SAMP 10 mice | neocortex and hippocampus | CV17, CV12, CV6, SP10, ST36 | not mentioned | QD for 14 days | p 130 pathway | elevation of p130 cell proliferation |
Liu T, et al. 2008[139] |
| |||||||
Male, SAMP8 mice | cortex and hippocampus | CV17, CV12, CV6, ST36, SP10 | MA, >2Hz | 30sec per acupoint, QD, 21 days | regulation of G protein/ IP3/ Ca2+ amplitude pathway | elevation of physiologically coupled activation rate and maximal coupled activation rate of Gαs and Gαi signal homeostasis |
Luo B, et al. 2017[140] |
| |||||||
Male, APP/PS1 mice | brain | GV20 | EA, 1mA, 2/15Hz | 30min, QD, 5 days/wk for 4 weeks | suppression of astrocytic NDRG2 pathway | depression of Glial fibrillary acidic protein, NDRG2 increase astrocytic reactivity |
Wang F, et al. 2014[141] |
| |||||||
telomerase-deficient mice(TERC-/-) mice | hippocampus and dentate gyrus | ST36 | MA | 30 min, QD for 4 days | activation of BDNF pathway | elevation of BDNF, TrkB, p75NTR, Akt, and ERK1/2 increase telomerase activity |
Lin D, et al. 2015[142] |
| |||||||
SD rat, beta-amyloid (Abeta)(1-40) injection | hippocampal | LI20, EX-HN3 | EA, 1-3mA, 80-100Hz | 10min, QD, 5 days/wk for 6 weeks | regulation of Bcl-2/Bax | elevation of Bcl-2 depression of Bax anti-apoptosis |
Liu ZB, et al. 2011[143] |
| |||||||
Male, SD rat, Aβ1-40 injection | hippocampus CA1 | GV20, BL23 | EA, <2mA, 20Hz | 30 min, QD, 6 days/ wk for 4 weeks | downregulation of Notch pathway | elevation of Bcl-2, synapsin-1, synaptophysin depression of Bax, Notch1 mRNA, Hes1 mRNA anti-apoptosis |
Guo HD, et al. 2015[144] |
| |||||||
Male, APP/PS1 mice | hippocampus | GV20, KI1 | EA, 1mA, 2/100Hz | 15min, QD for 3 days | inactivation of caspase-3/ Bax pathway | elevation of Bcl-2/Bax ratio depression of caspase-3-positive cell number and Bax protein anti-apoptosis |
Li XY, et al. 2016[145] |
| |||||||
APP/PS1 mice | hippocampus, cortex | GV20 | EA, 1/20Hz | 30min, QD, 5 days/wk for 4 weeks | regulation of AMPK/mTOR pathway | elevation of GLUT1, GLUT3, p-AMPK, p-Akt, mTOR decrease Aβ (1-42) deposition, decrease autophagy process |
Liu W, et al. 2017[148] |
| |||||||
Male, SAMP8 mice | hippocampus CA1 | GV14, BL23 | EA, 1mA, 2Hz | 20min, QD, 8 days' treatment and 2 days' rest for 3 cycles | activation of AMPK pathway | elevation of p-AMPK balance energy metabolism and improved cognitive impairment |
Dong W, et al. 2015[20] |
| |||||||
Male, SAMP8 mice | hippocampus and frontal cortex | GV14, BL23 | EA, 1mA, 2Hz | 20min, QD, 8 days' treatment and 2 days' rest for 3 cycles | activation of SIRT1-dependent PGC-1α expression pathway | elevation of ATP levels, SIRT1, PGC-1α depression of PGC-1α acetylation improved brain energy metabolism |
Dong W, et al. 2015[151] |
Abbreviations
Akt: protein kinase B; AMPK: AMP-activated protein kinase; APP/PS1: amyloid precursor protein (APP)/presenilin-1 (PS1) double transgenic; Bax: Bcl-2 associated X; Bcl-2: B-cell lymphoma 2; BDNF: brain-derived neurotrophic factor; CREB: phosphorylated cyclic AMP response element-binding protein; EA: electroacupuncture; ERK: extracellular signal-regulated kinase; GLUT: glucose transporter; IL: interleukin; IP3: Inositol triphosphate; MA: manual acupuncture; MAPK: mitogen-activated protein kinases; NDRG2: N-myc downregulated gene 2; NMDA: N-methyl-D-aspartate; PGC1: proliferator-activated receptor γ coactivator 1; PPAR-γ: peroxisome proliferator-activated receptors γ; QD: daily; QOD: every other day; RBL2: Retinoblastoma-like protein 2; SAMP: senescence-accelerated mouse prone; SD rat: Sprague Dawley rat; SIRT1: sirtuin 1; TrkB: tyrosine receptor kinase B.